News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Genentech (RHHBY)’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech (PBYI) Shares Jump     6/6/2017
Puma Biotech (PBYI) Defies Odds, Wins FDA Backing for Breast Cancer Drug     5/25/2017
Puma Biotech (PBYI) Surges on the FDA's Positive Breast Cancer Review     5/23/2017
Pfizer (PFE) Giving Out Cutting-Edge Cancer Drug for Free While Awaiting NHS Decision     5/5/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender     4/28/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted     4/24/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies     4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug     4/20/2017
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS)     3/21/2017
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars     3/3/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial     2/20/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business     2/15/2017
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January     12/22/2016
Celgene (CELG) Decides to Not Move Forward With Phase III Portion of tnAcity     12/7/2016
NICE U-Turns and Backs Approval of Roche (RHHBY)'s Perjeta for HER2-Positive Breast Cancer     11/22/2016

News from Around the Web
Blood-Based Breast Cancer Detection Test May Help Avoid Biopsy, Clinical Breast Cancer Reveals     5/26/2017
There’s A Therapeutic Curveball Heading For The FDA     5/25/2017
A Drink A Day Tied To Higher Breast Cancer Risk, American Institute for Cancer Research Report Says     5/24/2017
Trump's New HHS Appointee Yoest Thinks Abortion Raises Breast Cancer Risk, But Where's The Evidence?     5/2/2017
Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals     4/7/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug     2/17/2017
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
Biggest Breast Cancer Breakthrough: Map Links Cell Shape And Genes To Disease Outcomes, Institute of Cancer Research in London Study     2/6/2017
Were Women Foolish To Follow Angelina Jolie Into BRCA Cancer Gene Testing?     1/5/2017
Breast Cancer Cells Do Not Like It Spicy, Ruhr-University Study     12/22/2016
How 3 Huge Discoveries in 2016 are Moving Us Closer to a Breast Cancer Cure     10/24/2016
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016

Press Releases
Herantis Pharma's Lymfactin Study Advances To Last Patient Cohort, Company Announces Initial Plans For Continued Development     6/22/2017
Pfizer (PFE) Receives Expanded Health Canada Approval For IBRANCE In HR+, HER2- Metastatic Breast Cancer     6/21/2017
OncoCyte Reports Successful Completion Of Follow On Breast Cancer Diagnostic Study     6/15/2017
Agendia BV Release: Three New Studies Presented At ASCO Annual Meeting Demonstrate Benefits Of Mammaprint In Aiding Individualized Treatment Management For Early-Stage Breast Cancer Patients     6/13/2017
Cascadian Therapeutics (ONTY)’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation From FDA For Treatment Of Breast Cancer Patients With Brain Metastases     6/8/2017
2X Oncology Obtains Investigational New Drug Application For 2X-111 Glutathione Enhanced PEGylated Liposomal Doxorubicin     6/8/2017
Q Biomed Announces Commercialization Of Non-Narcotic Metastatic Cancer Pain Drug     6/8/2017
Cohera Medical Release: Tissuglu Surgical Adhesive Enables Drain-Free Recovery In Patients Undergoing DIEP Flap Breast Reconstruction     6/8/2017
Long Term Safety Data Published On Cytori (CYTX) Technology For Breast Reconstruction After Oncologic Surgery & Radiation Therapy     6/8/2017
AstraZeneca PLC (AZN) Release: LYNPARZA (Olaparib) Significantly Reduces The Risk Of Disease Worsening Or Death In Patients With BRCA-Mutated Metastatic Breast Cancer     6/6/2017
Genomic Health (GHDX): New Data Show Important Role Of Genomic Testing In Treatment Of Older Breast Cancer Patients     6/6/2017
Puma Biotech (PBYI) Gets A Leg Up As Genentech (RHHBY) Suffers Blow Over Breast Cancer Combo Therapy     6/5/2017
Eli Lilly (LLY) Builds Upon Body Of Data For Abemaciclib With Phase III MONARCH 2 Data Demonstrating Superior Progression-Free Survival In Advanced Breast Cancer     6/5/2017
NYU Langone Medical Center Release: Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer     6/5/2017
Daiichi Sankyo Release: New Precision Medicine Data On DS-8201 In HER2-Expressing Breast Cancer Revealed At 2017 ASCO Annual Meeting     6/5/2017